Yahoo
NYSE - Nasdaq Real Time Price USD

Oscar Health, Inc. (OSCR)

30.37 -0.42 (-1.36%)
At close: October 30 at 4:00:03 PM EDT
30.18 -0.19 (-0.63%)
After hours: October 30 at 7:43:10 PM EDT
Trade OSCR on Coinbase
Chart Range Bar
Loading chart for OSCR

What's happening with OSCR?

56m ago
Powered by Yahoo Scout

Oscar Health enters its November 5 earnings report with strong revenue-growth expectations, expanding 2027 marketplace coverage, and new consumer products. Analysts’ latest estimates remain stable, while valuation and regulatory oversight create competing considerations for investors.

Powered by Yahoo Scout
  • Previous Close 30.79
  • Open 30.56
  • Bid 30.16 x 30000
  • Ask 30.50 x 60000
  • Day's Range 29.94 - 30.87
  • 52 Week Range 10.69 - 35.01
  • Volume 3,637,240
  • Avg. Volume 5,271,458
  • Market Cap (intraday) 9.374B
  • Beta (5Y Monthly) 2.47
  • PE Ratio (TTM) 23.54
  • EPS (TTM) 1.29
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 36.40
  • Zacks Rating Bullish

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

www.hioscar.com

2,305

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OSCR
111.34%
S&P 500 (^GSPC)
10.73%

1-Year Return

OSCR
67.88%
S&P 500 (^GSPC)
11.11%

3-Year Return

OSCR
519.80%
S&P 500 (^GSPC)
81.91%

5-Year Return

OSCR
75.75%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 4.88B
Earnings 361.81M
Profit Margin 7.41%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
1B
2B
3B
4B
-10.0%
-5.0%
0.0%
5.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

27.00 Low
36.40 Average
30.37 Current
49.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/12/2026
Analyst UBS
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 26 -> 36

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.60%

  • Return on Assets (ttm)

    4.47%

  • Return on Equity (ttm)

    34.26%

  • Revenue (ttm)

    15.32B

  • Net Income Avi to Common (ttm)

    550.74M

  • Diluted EPS (ttm)

    1.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.56B

  • Total Debt/Equity (mrq)

    23.46%

  • Levered Free Cash Flow (ttm)

    692.53M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: